PD 0332991, a selective CDK4/6 inhibitor, preferentially inhibits growth of ovarian cancer cells with high Rb and low p16 (CDKN2A) expression Meeting Abstract

cited authors

  • Konecny, G., Winterhoff, B., Manivong, K., Qi, J., Kolarova, T., Kalli, K., Hartmann, L., Cliby, W., Finkler, N., Slamon, D.

Publication Date

  • March 1, 2010

webpage

published in

category

start page

  • S138

end page

  • S139

volume

  • 116

issue

  • 3

WoS Citations

  • 0

WoS References

  • 0